(Q54481739)

30 May 2018

title

p16(INK4a) /Ki-67 dual labelling as a marker for the presence of high-grade cancer cells or disease progression in urinary cytopathology. (English)

1 reference

30 May 2018

1 reference

E Piaton

1

1 reference

30 May 2018

A S Advenier

2

1 reference

30 May 2018

C Carré

3

1 reference

30 May 2018

M Decaussin-Petrucci

4

1 reference

30 May 2018

F Mege-Lechevallier

5

1 reference

30 May 2018

A Ruffion

6

1 reference

30 May 2018

publication date

25 September 2012

1 reference

30 May 2018

published in

Cytopathology

1 reference

30 May 2018

volume

24

1 reference

30 May 2018

issue

5

1 reference

30 May 2018

page(s)

327-334

1 reference

30 May 2018

Genetic alterations of p16INK4a and p14ARF genes in human bladder cancer.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01008.X

Expression of cell-cycle regulatory proteins and their prognostic value in superficial low-grade urothelial cell carcinoma of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01008.X

p16INK4a hypermethylation and p53, p16 and MDM2 protein expression in esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01008.X

Deletions of the INK4A gene in superficial bladder tumors. Association with recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01008.X

p16INK4a and p14ARF methylation as a potential biomarker for human bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01008.X

p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01008.X

p16ink4 immunoreactivity is a reliable marker for urothelial carcinoma in situ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01008.X

Immunohistochemical overexpression of p16 protein associated with intact retinoblastoma protein expression in cervical cancer and cervical intraepithelial neoplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01008.X

The sensitivity and specificity of p16(INK4a) cytology vs HPV testing for detecting high-grade cervical disease in the triage of ASC-US and LSIL pap cytology results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01008.X

p16/ki-67 dual-stain cytology in the triage of ASCUS and LSIL papanicolaou cytology: results from the European equivocal or mildly abnormal Papanicolaou cytology study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01008.X

Cost efficiency analysis of modern cytocentrifugation methods versus liquid based (Cytyc Thinprep) processing of urinary samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01008.X

Current status of urinary cytology in the evaluation of bladder neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01008.X

The accuracy of urinary cytology in daily practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01008.X

Value of urinary cytology in the diagnosis and management of urinary tract malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01008.X

Is urinary tract cytology still useful for diagnosis of bladder carcinomas? A large series of 592 bladder washings using a five-category classification of different cytological diagnoses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01008.X

An international telecytologic quiz on urinary cytology reveals educational deficits and absence of a commonly used classification system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01008.X

Monitoring patients for bladder neoplasms: what can be expected of urinary cytology consultations in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01008.X

p53 immunodetection of liquid-based processed urinary samples helps to identify bladder tumours with a higher risk of progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01008.X

Value of p16(INK4a) in the diagnosis of low-grade urothelial carcinoma of the urinary bladder in urinary cytology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01008.X

10.1111/J.1365-2303.2012.01008.X

21 January 2018

Identifiers

DOI

1 reference

30 May 2018

1 reference

30 May 2018